Literature DB >> 24371586

A case of villoglandular papillary adenocarcinoma of the cervix with vaginal skip metastasis.

M Gurumurthy, R Lahiri, A M Kennedy, I Miller, D E Parkin.   

Abstract

► First case of cervical villoglandular cancer with concurrent vaginal skip metastasis. ► Rapid progression to advanced stage with good response to adjuvant therapy.

Entities:  

Keywords:  Cervical cancer; Prognosis; Treatment; Vaginal metastasis; Villoglandular cervical cancer

Year:  2011        PMID： 24371586      PMCID： PMC3857684          DOI： 10.1016/j.gynor.2011.10.001

Source DB:  PubMed          Journal:  Gynecol Oncol Case Rep        ISSN： 2211-338X


  5 in total

1.  Villoglandular adenocarcinoma of the cervix: clarity is needed on the histological definition for this difficult diagnosis.

Authors:  R D Macdonald; J Kirwan; K Hayat; C S Herrington; H Shawki
Journal:  Gynecol Oncol       Date:  2005-11-02       Impact factor: 5.482

2.  Villoglandular papillary adenocarcinoma of the uterine cervix with aggressive clinical course--a case report.

Authors:  Roberta Rubesa-Mihaljević; Danijela Vrdoljak-Mozetic; Damjana Versa Ostojić; Snjezana Stemberger-Papić; Nebojsa Sindik; Maja Krasević
Journal:  Coll Antropol       Date:  2010-03

Review 3.  Term delivery following conservative treatment for villoglandular papillary adenocarcinoma of the uterine cervix: report of a case and analysis of the literature.

Authors:  J S Hoffman; L Bazzurini; L Laird; J C Murphy; U Magriples; J Lewis
Journal:  Gynecol Oncol       Date:  2001-05       Impact factor: 5.482

Review 4.  Villoglandular adenocarcinoma of the cervix: a report of three cases and review of the literature.

Authors:  H Stanley-Christian; B K Heim; J F Hines; K L Hall; G D Willett; W A Barnes
Journal:  Gynecol Oncol       Date:  1997-08       Impact factor: 5.482

5.  Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases.

Authors:  R H Young; R E Scully
Journal:  Cancer       Date:  1989-05-01       Impact factor: 6.860
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.